Epilepsia
-
Review Comparative Study
Estimating the cost of epilepsy in Europe: a review with economic modeling.
Based on available epidemiologic, health economic, and international population statistics literature, the cost of epilepsy in Europe was estimated. ⋯ Epilepsy is a relevant socioeconomic burden at individual, family, health services, and societal level in Europe. The greater proportion of such burden is outside the formal health care sector, antiepileptic drugs representing a smaller proportion. Lack of economic data from several European countries and other methodological limitations make this report an initial estimate of the cost of epilepsy in Europe. Prospective incidence cost-of-illness studies from well-defined populations and common methodology are encouraged.